Performance-based risk-sharing arrangements (PBRSAs) are one of many new schemes stakeholders are exploring, especially for specialty areas such as cardiovascular, oncology, and neurology. Good contract design and administration are integral for success.

Hear our experts discuss the state of PBRSAs and best practices including:

• Key considerations for designing effective performance contracts
• Current therapeutic areas of focus between payers and pharma
• Ways to better align data collection and outcomes measurement
• Considerations to address key regulatory and compliance challenges
• Recent public announcements of outcomes-based agreements between pharma and payers